AVROBIO Inc. (AVRO) – Management Comments
-
AVROBIO Inc. (AVRO) Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease
-
AVROBIO Inc. (AVRO) Reports New Positive Clinical Data and Preclinical Data for Lysosomal Disorder Gene Therapy Pipeline
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AVRO Stock Lookup